John W. Beck, Chief Financial Officer at METABASIS THERAPEUTICS INC (MBRX), sold 3,400 shares at $8.06 ($27K) on 2007-06-19, disclosed to the SEC on 2007-06-21.
Scheduled sale ($27k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.03 | 100 | $803 | 2.9% |
| 2 | $8.04 | 100 | $804 | 2.9% |
| 3 | $8.05 | 489 | $4K | 14.3% |
| 4 | $8.06 | 100 | $806 | 2.9% |
| 5 | $8.08 | 2,611 | $21K | 76.9% |
| Total | $8.07 avg | 3,400 |
| $27K |
| 100% |
| Filing → |
| RDEA | SELL | 2009-08-17 | $50K | — | Filing → |
| RDEA | SELL | 2009-05-21 | $75K | — | Filing → |
| MBRX | SELL | 2007-06-05 | $80K | — | Filing → |